Skip to main content
An official website of the United States government
Email

Funding Opportunities: AI in Cancer Research

NCI funds and supports extramural research to advance the use of AI in cancer research. Find out more about funding opportunities and other ways to engage in advancing AI for cancer research.

AI research is funded through a wide variety of grant and contract programs across NCI, where the majority of cancer research is supported through broad-based, investigator-initiated grant opportunities. The following programs have a strong emphasis on AI:

Specific open Funding Opportunities and Requests for Information are listed in the table below.

Notices of Funding Opportunities and Requests for Information
TitleAnnouncement NumberOpening DateExpiration DateActivity Code
Request for Information (RFI): Benchmarks for Artificial Intelligence in Cancer Research and CareNOT-CA-25-037May 14, 2025July 30, 2025N/A
Request for Information on Responsibly Developing and Sharing Generative Artificial Intelligence Tools Using NIH Controlled Access DataNOT-OD-25-118May 30, 2025July 16, 2025N/A
Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence/Machine Learning Tools for Improved Assessment in Biomedical and Behavioral ResearchNOT-CA-24-031Feb 13, 2024Jul 6, 2025(See NOSI)
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH)NSF 23-614 October 4, 2025(See NOFO)
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)PAR-25-079January 5, 2025Jan 8, 2027R01
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01—Clinical Trial Not Allowed)PAR-25-338January 5, 2025January 8, 2028R01
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)PAR-25-321Jan 16, 2025Jan 8, 2028R21
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)PAR-25-346Jan 16, 2025Jan 8, 2028R21

 

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Funding Opportunities: AI in Cancer Research was originally published by the National Cancer Institute.”

Email